The future of inflammatory bowel disease management

Matthew A. Ciorba

doi:10.1097/MOG.0000000000000856

The future of inflammatory bowel disease management

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	319-320
Number of pages	2
Journal	Current opinion in gastroenterology
Volume	38
Issue number	4
DOIs	https://doi.org/10.1097/MOG.0000000000000856
State	Published - Jul 1 2022

Access to Document

10.1097/MOG.0000000000000856

Cite this

@article{9b96800a6bfe4be283f041bd01b02f50,

title = "The future of inflammatory bowel disease management",

author = "Ciorba, {Matthew A.}",

note = "Funding Information: M.A.C. has received support from the NIDDK P30 DK052574, T32 DK007130, R01 DK109384, R56 AI167285, The Lawrence C. Pakula MD IBD Innovation Fund at Washington University and investigator-initiated sponsored research agreements from Pfizer (#61798927) and Janssen (NOPRODIBD0001). Funding Information: M.A.C. has received grants from Pfizer, Janssen, BMS, Takeda and AbbVie. M.A.C. has provided consulting services to Takeda, Pfizer, Janssen, BMS and Aclaris.",

year = "2022",

month = jul,

day = "1",

doi = "10.1097/MOG.0000000000000856",

language = "English",

volume = "38",

pages = "319--320",

journal = "Current opinion in gastroenterology",

issn = "0267-1379",

number = "4",

}

TY - JOUR

T1 - The future of inflammatory bowel disease management

AU - Ciorba, Matthew A.

N1 - Funding Information: M.A.C. has received support from the NIDDK P30 DK052574, T32 DK007130, R01 DK109384, R56 AI167285, The Lawrence C. Pakula MD IBD Innovation Fund at Washington University and investigator-initiated sponsored research agreements from Pfizer (#61798927) and Janssen (NOPRODIBD0001). Funding Information: M.A.C. has received grants from Pfizer, Janssen, BMS, Takeda and AbbVie. M.A.C. has provided consulting services to Takeda, Pfizer, Janssen, BMS and Aclaris.

PY - 2022/7/1

Y1 - 2022/7/1

UR - http://www.scopus.com/inward/record.url?scp=85133144387&partnerID=8YFLogxK

U2 - 10.1097/MOG.0000000000000856

DO - 10.1097/MOG.0000000000000856

M3 - Editorial

C2 - 35762690

AN - SCOPUS:85133144387

SN - 0267-1379

VL - 38

SP - 319

EP - 320

JO - Current opinion in gastroenterology

JF - Current opinion in gastroenterology

IS - 4

ER -

The future of inflammatory bowel disease management

Access to Document

Other files and links

Cite this